Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Polypharmacy-guideline issued by the Department of Internal Medicine (DIM) at the University Hospital Zurich (USZ)].

Praxis·2026
Same author

Effectiveness, feasibility, and acceptance of a general practice-based supportive intervention for dementia caregivers: the AD HOC trial.

European geriatric medicine·2026
Same author

Deprescribing antihypertensive medications in older people: a systematic review and a meta-analysis.

BMC geriatrics·2026
Same author

Age disparities in adverse reactions of drugs used in pain therapies in Switzerland.

Scientific reports·2025
Same author

The impact of Choosing Wisely<sup>TM</sup> recommendations and insurance coverage restrictions on the provision of low-value care: an interrupted time series analysis of vitamin D tests.

BMC health services research·2025
Same author

Factors facilitating or hindering the use of antibiotic-sparing treatment strategies in women with uncomplicated urinary tract infections: a scoping review.

Infection·2025
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

[Less is more - how to prevent polypharmacy?].

Stefan Neuner-Jehle1

  • 1Institut für Hausarztmedizin, Universitätsspital Zürich.

Praxis
|February 7, 2013
PubMed
Summary
This summary is machine-generated.

Reducing polypharmacy in elderly patients is crucial to prevent adverse events and improve health outcomes. Utilizing validated tools and strategies, alongside shared decision-making, can significantly enhance patient well-being.

Related Experiment Videos

Last Updated: May 14, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

  • Geriatric Medicine
  • Clinical Pharmacology
  • Patient Safety

Context:

  • Polypharmacy in elderly, polymorbid patients presents significant risks, including increased morbidity, hospitalization, and mortality.
  • Current medical practices often struggle to address the complexities of managing multiple medications in older adults.
  • Protecting healthy individuals from potentially harmful medical interventions is a critical healthcare challenge.

Purpose:

  • To present validated tools and strategies for reducing polypharmacy in elderly patients.
  • To highlight the importance of shared decision-making in medication management.
  • To emphasize the avoidance of underuse and inappropriate medication.

Summary:

  • The study introduces validated tools like Beer's list and Priscus list, and strategies such as the Medication Appropriateness Index and Good Palliative Geriatric Practice.
  • It advocates for a patient-centered approach, involving shared decision-making to reduce polypharmacy.
  • The core message is that reducing unnecessary medication, or 'less is more,' offers substantial benefits.

Impact:

  • Implementing these tools and strategies can significantly decrease the risk of adverse drug events and hospitalizations in the elderly.
  • Effective polypharmacy management can lead to improved quality of life and reduced healthcare costs.
  • This approach aims to optimize medication use, ensuring patients receive appropriate care and avoid harm.